Assertio Drug Patent Portfolio
Assertio owns 2 orange book drugs protected by 14 US patents Given below is the list of Assertio's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7662858 | Method of treating post-surgical acute pain | 24 Feb, 2029 | Active |
| US7884095 | Method of treating post-surgical acute pain | 24 Feb, 2029 | Active |
| US7939518 | Method of treating post-surgical acute pain | 24 Feb, 2029 | Active |
| US8110606 | Method of treating post-surgical acute pain | 24 Feb, 2029 | Active |
| US8623920 | Method of treating post-surgical acute pain | 24 Feb, 2029 | Active |
| US9561200 | Method of treating post-surgical acute pain | 24 Feb, 2029 | Active |
| US7759394 | Diclofenac formulations and methods of use | 16 Jun, 2026 | Active |
| US8097651 | Diclofenac formulations and methods of use | 16 Jun, 2026 | Active |
| US8927604 | Diclofenac formulations and methods of use | 16 Jun, 2026 | Active |
| US9827197 | Diclofenac formulations and methods of use | 16 Jun, 2026 | Active |
| US6365180 | Oral liquid compositions | 15 Jul, 2019 | Expired |
| US6287594 | Oral liquid compositions | 15 Jan, 2019 | Expired |
| US6974595 | Pharmaceutical compositions based on Diclofenae | 15 May, 2017 | Expired |
| US7482377 | Pharmaceutical compositions and methods of treatment based on diclofenac | 15 May, 2017 | Expired |
Latest Legal Activities on Assertio's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Assertio.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 07 Aug, 2023 | US8110606 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 17 Jul, 2023 | US8097651 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 10 Nov, 2022 | US7939518 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 08 Aug, 2022 | US7884095 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 06 Jul, 2022 | US8927604 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 20 Jan, 2022 | US7759394 |
|
Email Notification
Critical
| 19 Jan, 2022 | US9827197 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 19 Jan, 2022 | US9827197 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 19 Jan, 2022 | US8927604 |
|
Email Notification
Critical
| 19 Jan, 2022 | US8927604 |
|
Correspondence Address Change
Critical
| 18 Jan, 2022 | US9827197 |
|
Correspondence Address Change
Critical
| 18 Jan, 2022 | US8927604 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 16 Aug, 2021 | US7662858 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 28 May, 2021 | US9827197 |
|
Expire Patent
Critical
| 01 Mar, 2021 | US7482377 |
Assertio's Family Patents
Assertio Drug List
Given below is the complete list of Assertio's drugs and the patents protecting them.
1. Cambia
Cambia is protected by 6 patents, out of which 2 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7759394 | Diclofenac formulations and methods of use |
16 Jun, 2026
(1 year, 5 months from now)
| Active |
| US8097651 | Diclofenac formulations and methods of use |
16 Jun, 2026
(1 year, 5 months from now)
| Active |
| US8927604 | Diclofenac formulations and methods of use |
16 Jun, 2026
(1 year, 5 months from now)
| Active |
| US9827197 | Diclofenac formulations and methods of use |
16 Jun, 2026
(1 year, 5 months from now)
| Active |
| US6974595 | Pharmaceutical compositions based on Diclofenae |
15 May, 2017
(7 years ago)
| Expired |
| US7482377 | Pharmaceutical compositions and methods of treatment based on diclofenac |
15 May, 2017
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cambia's drug page
2. Zipsor
Zipsor is protected by 8 patents, out of which 2 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7662858 | Method of treating post-surgical acute pain |
24 Feb, 2029
(4 years from now)
| Active |
| US7884095 | Method of treating post-surgical acute pain |
24 Feb, 2029
(4 years from now)
| Active |
| US7939518 | Method of treating post-surgical acute pain |
24 Feb, 2029
(4 years from now)
| Active |
| US8110606 | Method of treating post-surgical acute pain |
24 Feb, 2029
(4 years from now)
| Active |
| US8623920 | Method of treating post-surgical acute pain |
24 Feb, 2029
(4 years from now)
| Active |
| US9561200 | Method of treating post-surgical acute pain |
24 Feb, 2029
(4 years from now)
| Active |
| US6365180 | Oral liquid compositions |
15 Jul, 2019
(5 years ago)
| Expired |
| US6287594 | Oral liquid compositions |
15 Jan, 2019
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zipsor's drug page